CKD-215
/ Chong Kun Dang
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 16, 2026
Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P1 trial • Fallopian Tube Cancer • Oncology • Ovarian Cancer • Peritoneal Cancer • Solid Tumor • BRCA
1 to 1
Of
1
Go to page
1